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Abstract
Background/objective: Zingiber officinale Roscoe (ginger) (Zingiberaceae) has been cultivated for thousands of
years both as a spice and for medicinal purposes. Ginger rhizomes successive extracts (petroleum ether, chloroform
and ethanol) were examined against liver fibrosis induced by carbon tetrachloride in rats.
Results: The evaluation was done through measuring antioxidant parameters; glutathione (GSH), total superoxide
dismutase (SOD) and malondialdehyde (MDA). Liver marker enzymes; succinate and lactate dehydrogenases (SDH
and LDH), glucose-6-phosphatase (G-6-Pase), acid phosphatase (AP), 5’- nucleotidase (5’NT) and liver function
enzymes; aspartate and alanine aminotransferases (AST and ALT) as well as cholestatic markers; alkaline
phosphatase (ALP), gamma glutamyl transferase (GGT), total bilirubin were estimated. Liver histopathological
analysis and collagen content were also evaluated. Treatments with the selected extracts significantly increased
GSH, SOD, SDH, LDH, G-6-Pase, AP and 5’NT. However, MDA, AST, ALT ALP, GGT and total bilirubin were
significantly decreased.
Conclusions: Extracts of ginger, particularly the ethanol one resulted in an attractive candidate for the treatment
of liver fibrosis induced by CCl4. Further studies are required in order to identify the molecules responsible of the
pharmacological activity.
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1. Background
Liver plays a pivotal role in regulating various physiolo-
gical processes in the body such as metabolism, secre-
tion and storage. It has great capacity to detoxicate
toxic substances and synthesize useful principles. There-
fore, damage on the liver inflicted by hepatotoxic agents
is of grave consequences [1].
Evidences developed over the last years have suggested
that various forms of liver injuries may be caused by
free radical formation and subsequent oxidative stress. It
is believed that reactive oxygen species (ROS), such as
hydroxyl radical, superoxide radical anion and nitric
oxide may injure cell membranes through lipid peroxi-
dation [2]. Apparently ROS modify or damage biomole-
cules, i.e., proteins, lipids, carbohydrates and DNA [3].
Oxidative stress lead to the formation of glycoxidation
products, including advanced glycation end products
(AGEs - among them Nε-(carboxymethyl) lysine (CML)
is best known), and advanced oxidation protein products
(AOPPs). The receptor for advanced glycation end pro-
ducts (RAGE) is a signal transduction receptor that
binds both AGEs and AOPPs. RAGE is expressed by
hepatic stellate cells and myofibroblasts, which are the
relevant cells for fibrogenesis of chronic liver disease.
Both AGEs and AOPPs trigger the inflammatory
response via interaction with RAGE and by causing acti-
vation of nuclear factor NF-B [4]. Since advanced oxi-
dation protein products are not only markers of
oxidative stress but also act as inflammatory mediators
[5], the knowledge of AOPPs pathophysiology in chronic
liver disease could provide valuable information with
respect to the relationship between oxidative stress and
the inflammatory response related to liver fibrosis [6].
Carbon tetrachloride (CCl4), as a xenobiotic, caused
oxidative stress and may injuries hepatic cells [7]. Many
studies have established the fact that CCl4 is metabo-
lized in the liver into a highly reactive substance,
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any medium, provided the original work is properly cited.trichloromethyl, which initiate free radicals that mediate
lipid peroxidation [8].
For this reason, anti-oxidation is an extremely signifi-
cant activity which can be used as a preventive agent
against diseases [9]. In spite of tremendous advances in
modern medicine, there are no effective drugs available
to improve liver function, offer protection or help to
regenerate hepatic cells [1]. In absence of reliable liver-
protective drugs, therefore, attention is focused on nat-
ural antioxidants. Natural antioxidants are polyphenol
compounds which are found in all plants [10].
Ginger (Zingiber officinale Roscoe; Zingiberaceae) has
been used as a spice for over thousand years [11]. Its
roots contain polyphenol compounds (6-gingerol and
shogaols), which have a high antioxidant activity [12]. In
addition, ginger reported as detoxifying agent against
alcohol abuse [13] and bromobenzene intoxication [14].
Matsuda et al. [15] and Habib et al. [16] mentioned its
antidiabetic, antihyperlipidimic and hepatic anticancer
effect.
According to glossary produced by American Dia-
betics and Association, neutriceutics are substances con-
s i d e r e da sf o o do rap a r to fi tt h a to f f e r sh e a l t ho r
medicinal benefit, including prevention and treatment of
diseases [17]. Some of the natural products find their
use not as pharmaceuticals (real medicine) but as a
novel class of dietary supplements or nutraceuticals that
fall well into the concept of functional foods. Ginger has
been listed in ‘’Generally Recognized as Safe’’ (GRAS)
document of the US FDA, where a dose of 0.5-1.0 g of
ginger powder ingested 2-3 times for periods ranging
from 3 months to 2.5 years did not cause any adverse
effects [18].
Despite the favorable ethnopharmacological properties
of ginger, its protective effect against liver fibrosis has
not previously been explored and its role as diminished
factor of fibrosis could be a marker of therapeutic bene-
fit. The aim of the present study was to evaluate succes-
sive ginger extracts (petroleum ether, chloroform and
ethanol) against liver fibrosis induced by CCl4 in rats.
The evaluation was done through measuring certain
antioxidant parameters, hepatic marker enzymes, liver
function indices, cholestatic biomarkers and histological
analysis of the liver sections.
2. Material and methods
2.1. Chemicals
A l lc h e m i c a l si nt h ep r e s e n ts t u d yw e r eo fa n a l y t i c a l
grade, product of Sigma (US), Merck (Germany) and
BDH (England).
2.2. Plant collection
Ginger rhizomes were purchased from local market
(Hyper One, 6
th October City, Egypt) and identified by
Dr. Manal Shabana, Phytochemistry and Plant Systema-
tic Department, National Research Center, Egypt. Vou-
cher specimen (ZOR-2010) was deposited as a reference
at Therapeutic Chemistry Department, NRC. Dried rhi-
zomes were ground in a grinder with 2 mm diameter
mesh and kept in tightly closed container until needed.
2.3. Plant Extraction
The dried powdered rhizomes (500 g) were successively
extracted in a Soxhlet apparatus using solvents of
increasing polarities: petroleum ether (40-60°C), chloro-
form and 95% ethanol for 72 h of each solvent [19]. Sol-
vent removal was carried by evaporation under reduced
pressure at 40°C yielding semisolid residues of 1.3, 0.80
and 2.35% w/w, respectively.
2.4. Phytochemical screening
All extracts were tested for carbohydrates, sterols, ter-
penes [20], flavonoids, tannins, oils [21] and alkaloids
[22].
2.5. Animals
Male Wistar albino rats (100: 120 g) were selected for
this study. They were obtained from the Animal House,
National Research Center, Egypt. All animals were kept
in controlled environment of air and temperature with
access of water and diet. Anesthetic procedures and
handling with animals complied with the ethical guide-
lines of Medical Ethical Committee of National Research
Centre in Egypt (Approval no: 10031).
2.6. Doses and route of administration
Administration regimen was twice a week for six conse-
cutive weeks. CCl4 (0.5 ml/kg) was suspended in olive
oil (1:9 v/v) and injected intraperitoneally [23]. Ginger
extracts were administrated orally at a dose 200 mg/kg)
[14]. Silymarin; a reference herbal drug was orally admi-
nistered at a dose 100 mg/kg [24].
Normal control group was orally vehicle with 0.5 ml
normal physiological saline and intraperitoneally
received 0.5 ml olive oil. Control groups treated with
ginger extracts were intraperitoneally vehicle with 0.5
ml olive oil. CCl4 group was orally vehicle with 0.5 ml
of normal physiological saline.
2.7. Experimental groups
72 male Wistar strain albino rats were used in this
study. Animals were divided into 9 groups (8 rats each).
Group1 served as normal healthy control rats. Groups
2-4 were normal healthy rats administered with ginger
extracts (petroleum ether, chloroform and ethanol).
Group 5 injected with CCl4. Groups 6-8 forced at the
same time with CCl4 and ginger extracts. Group 9
forced with CCl4 and silymarin drug.
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Serum sample: Blood collected from each animal by
puncture the sublingual vein in clean and dry test tube,
left 10 min to clot and centrifuged at 3000 rpm (4°C)
for serum separation. The separated serum was stored
at -80°C for further determinations of liver function
enzymes, cholestatic biomarkers and serum protein.
Liver tissue was homogenized in normal physiological
saline solution (0.9% NaCl) (1:9 w/v). The homogenate
was centrifuged at 4°C for 5 min at 3000 rpm. The
supernatant was used for estimation of liver marker
enzymes and the antioxidant parameters.
2.9. Biochemical assays
2.9.1. Antioxidant parameters
Malondialdehyde as a product of polyunsaturated fatty
acids oxidation was determined by the method of Buege
and Aust [25]. Its concentration was calculated using
the extinction coefficient value 1.56 × 10
5 M
-1 cm
-1 and
read at 535 nm. Glutathione was assayed by the method
of Moron et al. [26] using dithiobis-2-nitrobenzoic acid
(DTNB) in PBS. The reaction colour was read at 412
nm. Total superoxide dismutase was estimated by
method of Nishikimi et al. [27 ] ,w h e r et h ei n c r e a s ei n
NADH oxidation was measured at 560 nm using its
molar extinction coefficient 6.22 × 10
3 M
-1 cm
-1.
2.9.2. Hepatic cell organelles markers
Succinate dehydrogenase; a marker for mitochondria
was estimated by the method of Rice and Shelton [28],
where the reduction of flavin adenine dinucleotide was
coupled with a reduction of tetrazolium salt as 2-p-iodo-
phenyl-3-p-nitrophenyl-5-phenyl tetrazolium chloride
(INT) and the produced formazan of INT was measured
colorimetrically at 490 nm. Lactate dehydrogenase; a
marker for cytoplasm was estimated by the method of
Babson and Babson [29], where the reduction of nucleo-
side derived amino acids (NAD) was coupled with the
reduction of tetrazolium salt and the produced formazan
of INT was measured colorimetrically at 503 nm. The
three enzymes, G-6-Pase (microsome marker), acid
phosphatase (lysosome marker) and 5’- nucleotidase
(plasma membrane marker) were measured colorimetri-
cally as inorganic phosphorus released at 660 nm
[30-32], respectively.
2.9.3. Serum biomarkers for liver function tests and total
protein level
Aspartate and alanine amintransferases were measured
by the method of Gella et al. [33], where the transfer of
amino group from aspartate or alanine formed oxalace-
tate or pyruvate, respectively and the developed colour
was measured at 520 nm. Total protein was assayed by
the method of Bradford [34], where Coomassie Brilliant
Blue dye reacted with Bradford reagent and gave a blue
complex at 595 nm.
2.9.4. Cholestatic indices
Alkaline phosphatase catalyzed in alkaline medium the
transfer of phosphate group from 4-nitrophosphatase to
2-amino-2-methyl-1-propanol (AMP) and librated 4-
nitrophenol. The developed colour was measured at 510
nm [35]. GGT was estimated by the method of Szasz
[36], where GGT enzyme reacted with L-g - glutamyl-3-
carboxy-p-nitroanilide and glycyl-glycine to give L-g -
glutamyl-glycyl-glycine and 5-amino-2-nitrobenzoate.
The decrease in absorbance was read at 450 nm at 1
min intervals for 3 minutes. Total bilirubin was mea-
sured by the method of Doumas et al. [37], where it
reacted with diazotized sulfanilic acid in the presence of
caffeine with final azo-pigment product. The developed
colour was read at 546 nm.
2.10. Histopathological study
Liver slices were fixed in 10% paraformaldehyde and
embedded in paraffin wax blocks. Sections of 5 μm
thick were stained with hematoxylin & eosin (H&E) and
Masson’s trichrome, then examined under light micro-
scope for determination of pathological changes [38].
Collagen content was determined in Masson’s trichrome
sections and expressed as collagen volume, where
volume of collagen (%) = number of points failing on 10
successive fields/number of points in the reticule (1 cm
2
eye piece reticule) × 100 [39].
2.11. Statistical analysis and calculations
All data were expressed as mean ± SD of eight rats in
each group. Statistical analysis was carried out by one-
way analysis of variance (ANOVA), Costat Software
Computer Program. Significance difference between
groups was at p < 0.05.
% change = control mean - treated mean/control
mean × 100.
% improvement = treated mean - injured mean/con-
trol mean × 100.
3. Results
3.1. Phytochemical screening
Phytochemical screening of ginger ethanolic extract
revealed abundant presence of flavonoids and tannins.
High concentration of carbohydrates and moderate con-
centration of alkaloids were recorded. Chloroformic
extract contained moderate concentrations of sterols
and terpenes, while petroleum ether one contained
moderate lipids content (Table 1).
3.2. Extracts safety
Normal healthy rats administrated with ethanol and
chloroform extracts recorded insignificant changes in all
parameters under investigation revealing extracts safety.
Petroleum ether extract showed significant changes in
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Tables S1-S5).
3.3. Effect of Zingiber officinale on hepatic antioxidant
levels
CCl4 group recorded significant decrease in glutathione
(63.63%) and total SOD (49.73%) levels, while malon-
dialdehyde showed significant increase by 38.00% (Table
2). Treatment with ethanol extract improved MDA and
SOD levels by 60.56 and 10.70%, respectively. Glu-
tathione enhanced after treatment with chloroform and
ethanol extracts by 32.70 and 27.97%. Treatment with
silymarin recorded improvement in GSH, MDA and
SOD by 40.08, 35.21 and 3.84%, respectively.
3.4. Efficiency of Zingiber officinale on hepatic marker
enzymes
Fibrotic liver induced by CCl4 recorded significant
decrease in SDH, LDH, G-6-Pase, AP and 5’NT by
22.65, 32.50, 24.40, 35.13 and 47.22%, respectively
(Table 3). Treatment with ginger extracts recorded
improvement in all marker enzymes, whereas ethanolic
extract showed higher improvement percentages than
the other ones. It recorded enhancement by 13.85, 9.42,
20.60 and 25.41% for SDH, G-6-Pase, AP and 5’NT,
respectively. Contradictory, LDH enzyme recorded
higher improvement level after treatment with petro-
leum ether extract (29.9%) (Table 3). Treatment with
silymarin improved SDH, LDH, G-6-Pase, AP and 5’NT
by 6.39, 23.76, 8.69, 8.18 and 17.77%, respectively.
3.5. Potency of Zingiber officinale in improving liver
function enzymes and serum protein
CCl4 group, showed significant increase in AST and
ALT levels by 88.34 and 43.52%, respectively (Table 4).
However, serum total protein was insignificantly
increased by 8.93, 6.97 and 3.91% after treatment with
ethanol, chloroform and petroleum ether extracts,
respectively. The observed changes in liver function
enzymes showed that ethanol extract recorded the most
improvement percentages than the other extracts. AST
and ALT were ameliorated by 31.11 and 21.26%, while
serum protein was improved by 15.19, 13.24 and 12.39%
for the three extracts, respectively. Silymarin enhanced
AST, ALT and total protein levels by 36.66, 22.84 and
12.39%, respectively.
3.6. Efficacy of Zingiber officinale on serum cholestatic
markers
As compared to normal healthy rats, CCl4 group
recorded significant increase in GGT, ALP and total
bilirubin by 55.70, 46.61 and 157.14%, respectively
(Table 5). Improvement in serum cholestatic biomarkers
after treatment revealed that all extracts shared in
improvement by high percentages. Treatment with etha-
nol extract recorded the highest improving percent in
GGT and total bilirubin (53.99 and 154.76%). ALP
enhanced by 33.81, 44.74 and 41.29% after treatment
with ethanol, chloroform and petroleum ether extracts,
respectively. GGT, ALP and total bilirubin recorded
improvement percentages reached to 43.85, 33.81 and
152.38% after silymarin treatment.
Table 1 Phytochemical screening of successive ginger
extracts
Constituents Petroleum ether Chloroform Ethanol
Carbohydrate - - +++
Flavonoids - - ++++
Tannins - - ++++
Sterols - ++ -
Terpenes - ++ -
Alkaloids - - -
Oils ++ - -
●
- = Not present.
● + = Present in low concentration.
● ++ = Present in moderately high concentration.
● +++ = Present in very high concentration.
● ++++ = Abundantly present.
Table 2 Effect of Zingiber officinale extracts on hepatic antioxidant levels in CCl4 treated rats
Parameters Control CCl4 group CCl4 treated
with
ethanol extract
CCl4 treated with
chloroform
extract
CCl4 treated with
petroleum
ether extract
CCl4 treated with
silymarin
GSH 783.81 ±
124.87
(a)
285.00 ±
59.42
(c)
504.26 ± 59.49
(b)
541.35 ± 85.34
(b)
523.58 ± 66.47
(b)
599.16 ± 128.39
(b)
MDA 0.71 ± 0.12
(b)
0.98 ± 0.25
(a)
0. 77 ± 0.04
(b)
0.76 ± 0.12
(b)
0.78 ± 0.14
(b)
0.73 ± 0.03
(b)
Total SOD 16.91 ± 2.63
(a)
8.50 ± 1.76
(b)
10.31 ± 2.53
(b)
9.76 ± 2.45
(b)
9.41 ± 1.97
(b)
9.15 ± 2.70
(b)
● Data are means ± SD of eight rats in each group.
● Data are expressed as μg/mg protein for GSH and μmol/mg protein for MDA and total SOD.
● Unshared letters between groups are the significance values at p < 0.0001.
● Statistical analysis is carried out using one way analysis of variance (ANOVA), CoStat Computer Program.
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relative body weights
CCl4 intoxicated rats showed significant increase in liver
weight (LW) and its ratio over body weight (LW/BW)
by 21.21 and 69.39%, respectively. However body weight
(BW) recorded significant decrease by 28.37% (Table 6).
Regarding to the recorded changes in LW, BW and
their ratios, ethanol extract showed improvement by
17.92, 12.88 and 39.89%, respectively. Treatment with
petroleum ether extract showed enhancement by 14.80,
10.66 and 34.42%, while chloroform extract recorded
enhancement values by 7.07, 3.92 and 34.69% (Table 6).
Silymarin treatment improved LW, BW and their ratio
by 0.16, 25.55 and 43.16%, respectively.
3.8. Effect of Zingiber officinale on collagen content in
CCl4 treated liver
Normal healthy liver of control and control treated with
ethanol and chloroform extracts of ginger recorded 5%
collagen deposition. Normal liver treated with petroleum
ether extract exerted 10% collagen content. CCl4 injured
liver revealed 70% collagen deposition. Treatment with
ethanol, chloroform, petroleum ether extracts and sily-
marin recorded decrease in collagen content by 85.71,
64.28, 28.57 and 78.57%, respectively (Figure 1).
3.9. Effect of Zingber officinale on liver morphology
CCl4 induced changes in liver morphology as compared
with normal healthy one (Figure 2-a). Liver colour had
changed from normal reddish brown to more or less
light brown; a stage of steatosis. The liver enlarges in
s i z ea n dl o s ti t ’s smoothly surface. Scattered patches of
inflammations and pale yellowish fibrotic areas had been
seen along with long fibrotic girdle surrounded the
outer liver margin (Figure 2-b). Treatment with ethanol
extract had returned the liver to it’s smoothly appear-
ance, normalized its colour and size and diminished the
fibrotic spots to be minimal (Figure 2-c). Chloroform
extract of ginger improved the morphological structure
of the liver, while a fibrotic area was seen in the hepatic
Table 3 Effect of Zingiber officinale extracts on hepatic marker enzymes in CCl4 treated rats
Parameters Control CCl4 group CCl4 treated with
ethanol extract
ethanol extract
CCl4 treated with
chloroform extract
chloroform extract
CCl4 treated with
petroleum ether
extract
CCl4 treated with
silymarin
SDH 108.86 ± 24.2
(a)
84.2 ± 24.2
(b)
99.28 ± 10.05
(ab)
93.79 ± 6.79
(ab)
96.16 ± 23.51
(ab)
91.16 ± 8.29
(ab)
LDH 143.86 ± 18.12
(a)
97.01 ± 41.09
(c)
124.04 ± 27.63
(abc)
100.83 ± 12.93
(bc)
140.06 ± 2.44
(a)
131.2 ± 35.16
(ab)
G-6-Pase 43.48 ± 4.83
(a)
32.87 ± 2.24
(b)
36.97 ± 10.31
(ab)
34.07 ± 7.9
(b)
36.55 ± 2.39
(ab)
36.65 ± 6.33
(ab)
AP 63.53 ± 6.73
(a)
41.21 ± 2.55
(d)
54.3 ± 3.01
(b)
48.25 ± 3.14
(c)
48.35 ± 4.79
(c)
46.41 ± 3.19
(c)
5’NT 304.25 ± 58.81
(a)
160.83 ±
29.38
(d)
238.17 ± 5.79
(b)
215.63 ± 21.42
(bc)
192.18 ± 14.9
(cd)
214.9 ± 47.4
(bc)
● Data are means ± SD of eight rats in each group.
● Data are expressed as μmole/min/mg protein.
● Unshared letters between groups are the significance values at p < 0.0001.
● Statistical analysis is carried out using one way analysis of variance (ANOVA), CoStat Computer Program.
Table 4 Effect of Zingiber officinale extracts on liver function enzymes and total protein level in serum of CCl4 treated
rats
Parameters Control CCl4 group CCl4 treated
with
ethanol extract
CCl4 treated with chloroform
extract
chloroform extract
CCl4 treated with
petroleum ether
extract
CCl4 treated with
silymarin
AST 16.39 ± 1.67
(c)
30.87 ± 3.35
(a)
25.44 ± 2.00
(b)
27.22 ± 2.23
(b)
27.72 ± 2.82
(b)
24.86 ± 3.37
(b)
ALT 33.57 ± 4.07
(c)
48.31 ± 6.20
(a)
41.17 ± 8.38
(ab)
42.26 ± 7.45
(ab)
44.82 ± 2.84
(ab)
40.64 ± 7.72
(bc)
Serum
protein
15.33 ± 4.04
(b)
18.36 ± 1.35
(a)
16.03 ± 0.74
(ab)
16.33 ± 0.72
(ab)
16.46 ± 0.30
(ab)
16.46 ± 1.30
(ab)
● Data are means ± SD of eight rats in each group.
● Liver functions are expressed as Unit/L. Total protein is expressed as mg P/ml.
● Unshared letters between groups are the significance values at p < 0.0001.
● Statistical analysis is carried out using one way analysis of variance (ANOVA), CoStat Computer Program.
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worst appearance, where large patches as well as many
spots of fibrosis were scattered along the liver (Figure 2-
e). Treatment with silymarin minimally improved the
morphological structure of the liver. Many area of fibro-
sis along the whole liver surface were spread and
marked inflammations along the border of the hepatic
lobes were observed (Figure 2-f).
3.10. Liver histopathological analysis
Fig. (3 a, b) showed liver section of control healthy rats
with normal hepatic lobular architecture. The hepato-
cytes were within normal limits and arranged in thin
plates. The hepatocytes were separated by narrow blood
sinusoids lined by endothelial cells. Portal tracts extend
with no fibrous tissue or lymphocytes deposition. Healthy
rats treated with ethanolic extract showed normal hepatic
lobular architecture. The hepatocytes were within normal
limits and no hydropic or steatosis changes. Portal tracts
were normal and no sign of fibrosis (Figure 3 c, d). Treat-
ment with chloroform extract of ginger recorded more or
less normal hepatocytes architecture (Figure 3 e, f). Pet-
roleum ether extract caused mild hepatocytes aggregation
and lymphocytes infiltrations (Figure 3 g, h).
Injured liver with CCl4 showed portal loss of hepatic
lobular architecture. Ballooning of hepatocytes,
deformed cord arrangement and disturbed sinusoids
were seen. The hepatocytes showed marked degree of
hydropic, steatotic changes and massive necrosis. Portal
tracts were extended with marked numbers of chronic
inflammatory cells and fibrous tissue. There were porto-
portal and porto-central fibrosis. Fibrosis was markedly
presented by 70% (Figure 4 a, b, c).
Treatments of injured liver with the ethanol extract
showed well formed nucleated hepatocytes arranged in
cord with obvious sinusoidal arrays. Minimal fat
vacuoles and minimal inflammatory lymphocyte infiltra-
tions were observed. Fibrosis reached to 10% (Figure 4
d, e). Chloroform extract partly preserved the hepatic
normal architecture. Mild degrees of steatosis and
hydropic changes were recorded. The hepatocytes were
still swollen with narrow sinusoids. Portal tracts were
extended with moderate fibrous tissue reached to 25%
(Figures 4 f, g). Petroleum ether extract showed narrow
sinusoids, ballooning and foamy appearance of heapato-
cytes. Portal tracts were extended with moderate fibrous
tissue reached to 50% (Figure 4 h, i). CCl4 group treated
with silymarin showed well arranged cord of nucleated
hepatocytes and sinusoids, while mild fibrotic tissue was
still present (15%) (Figure 4 j, k).
4. Discussion
Hepatoprotective studies showed that plants have active
ingredients that are capable of free radical scavenging in
Table 5 Effect of Zingiber officinale extracts on serum cholestatic markers in CCl4 treated rats
Parameters Control CCl4 group CCl4 treated
with
ethanol extract
CCl4 treated with chloroform
extract
CCl4 treated with
petroleum ether
extract
CCl4 treated with
silymarin
GGT 15.78 ± 1.53
(bc)
24.57 ± 3.48
(a)
16.05 ± 2.49
(c)
20.25 ± 6.22
(ab)
17.55 ± 4.57
(bc)
17.65 ± 5.46
(bc)
ALP 13.90 ± 1.41
(b)
20.38 ± 4.37
(a)
15.68 ± 5.82
(b)
14.16 ± 3.67
(b)
14.64 ± 2.30
(b)
15.68 ± 2.37
(b)
Total
bilirubin
0.42 ± 0.10
(a)
1.08 ± 1.43
(b)
0.43 ± 0.09
(a)
0.45 ± 0.11
(a)
0.46 ± 0.11
(a)
0.44 ± 0.07
(a)
● Data are means ± SD of eight rats in each group.
● Data are expressed as Unit/L in GGT, ALP and mg/dL in total bilirubin.
● Unshared letters between groups are the significance values at p < 0.001.
● Statistical analysis is carried out using one way analysis of variance (ANOVA), CoStat Computer Program.
Table 6 Effect of Zingber officinale extracts on liver and body weights of CCl4 treated rats
Parameters Control CCl4 group CCl4 treated with
ethanol extract
CCl4 treated with
chloroform extract
CCl4 treated with
petroleum ether extract
CCl4 treated with silymarin
Liver weight
(LW)
6.08 ± 0.71
(b)
7.37 ± 0.95
(a)
6.28 ± 0.59
(b)
6.94 ± 1.06
(ab)
6.47 ± 0.93
(ab)
7.36 ± 0.48
(a)
Body weight
(BW)
165.66 ± 12.95
(a)
118.66 ± 4.32
(c)
140.00 ± 11.83
(b)
125.16 ± 12.25
(bc)
136.33 ± 26.88
(b)
161.00 ± 6.38
(a)
%
(LW/BW)
3.66 ± 0.24
(c)
6.20 ± 0.66
(a)
4.74 ± 0.96
(b)
4.93 ± 0.52
(b)
4.94 ± 0.57
(b)
4.62 ± 1.02
(b)
● Data are means ± SD of eight rats in each group.
● Data are expressed as grams.
● Unshared letters between groups are the significance values at p < 0.0001.
● Statistical analysis is carried out using one way analysis of variance (ANOVA), CoStat Computer Program.
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alkaloids as antioxidative compounds are rich in most
plants [40]. In the present study and in accordance with
Anosike et al. [41], high content of these compounds
was recorded in the ethanol extract of ginger followed
by chloroform one suggesting their potential role as
antioxidative agents.
CCl4 is one of an extensively environmental toxicant.
The reactive metabolite trichloromethyl radical (CCl3
-)
has been formed from the metabolic conversion of CCl4
by cytochrome P-450. This reactive metabolite initiates
the peroxidation of membrane poly-unsaturated fatty
acids (PUFA), generates PUFA radicals, covalently binds
to membrane lipids and proteins and generates ROS
[42]. Evidence suggests that various enzymatic and non-
enzymatic systems have been developed by the cell to
attenuate ROS. However, when a condition of oxidative
stress establishes, the defense capacities against ROS
becomes insufficient. Therefore, ROS affects the antioxi-
dant defense mechanisms, reduces the intracellular con-
centration of GSH, decreases the activity of SOD and
enhances lipid peroxidation [43]. In agreement with
these explanations, the observed decrease in SOD was
recorded in CCl4 treated rats that may be due to inacti-
vation of the antioxidative enzymes. This may cause an
increased accumulation of superoxide radicals, which
could further stimulate lipid peroxidation. Decrease in
GSH activity might be due to decrease availability of
Figure 1 Percentages of collagen deposition in normal and
CCl4 treated livers. Normal control (I), control treated with ethanol
extract (II), control treated with chloroform extract (III), control
treated with petroleum ether extract (IV), CCl4 group(V), CCl4 treated
with ethanol extract (VI), CCl4 treated with chloroform extract (VII),
CCl4 treated with petroleum ether extract (VIII) and CCl4 treated
with silymarin (IX).
Figure 2 Morphological structure of normal and CCl4 treated
livers. Normal control (a), CCl4 injured liver (b), CCl4 treated with
ethanol extract (c), CCl4 treated with chloroform extract (d), CCl4
treated with petroleum ether extract (e) and CCl4 treated with
silymarin drug (f).
Figure 3 Photomicrograph of H&E and Masson’st r i c h r o m
stained liver sections (100×) of control (a,b), control treated
with ethanol extract (c,d), control treated with chloroform
extract (e,f) and control treated with petroleum ether extract
(g,h). Central vein (CV). Arrows indicate collagen deposition.
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processes.
Treatment with ginger extracts normalized the antioxi-
dant levels through their rich of flavonoids that have the
ability to scavenge free radicals. Silymarin as an antioxi-
dant flavonoid complex derived from the herb milk this-
tle (Silybum marianum), has the ability to attenuate free
radicals elevation, chelates metal ions, inhibits lipid per-
oxidation and prevents liver glutathione depletion [44].
ALT and AST had been reported to be sensitive indi-
cators of liver injury [45]. Significant elevation of ALT
and AST after CCl4 intoxication was in agreement with
those reported studies of Opoku et al. [40] and Gowri
Shankar et al. [42]. In addition, Romero et al. [46]
showed that CCl4 intoxication induced changes in the
process of protein synthesis. Hence, increase in total
protein content can be deemed as a useful index of the
severity of cellular dysfunction in liver diseases as
clearly shown in our studies. Stimulation of protein
synthesis has been advanced as a contributory self heal-
ing mechanism, which accelerates liver regeneration
process [47].
Enhancement of cholestatic biomarkers; ALP, GGT
and bilirubin were observed in the present study. This
was in agreement with Reyes-Gordillo et al. [48] who
recorded significant increase in cholestasis biomarker
after intoxication of rats with CCl4. Leonard et al. [49]
confirmed GGT and bilirubin as indicators of bile duct
lesions. Hamed [50] added that GGT alone is a poor
indicator of cytotoxicity and suggested the combination
of other markers like AST, ALT and LDH for accurate
detection and early diagnosis. Opoku et al. [40] and
Gowri Shankar et al. [42] explained serum enzymes ele-
vation to the increase in hepatic cell membrane fluidity
that led to enzyme release into circulation.
Treatment with ginger extracts attenuated the
increased level of serum enzymes and caused a subse-
quent recovery towards normalization. This give an
additional support that ginger extracts are able to condi-
tion the hepatocytes, accelerate regeneration of parench-
yma cells, protect against membrane fragility and
decrease leakage of the enzymes into circulation. There-
fore, plant extracts acted by the same mode of action of
silymarin [42].
Stressful condition also contribute to the oxidative
inactivation of G-6-Pase and 5’- nucleotidase [51].
Inhibition of G-6-Pase and 5’NT activities, in our
study, are in agreement with the findings of Opoku et
al. [40] and Nkosi et al. [52]. The decreased activities
of these marker enzymes during CC14 poisoning con-
firm microsomal and plasma membrane damage.
Though these two enzymes are active in two different
metabolic pathways, their functional integrity depends
on the chemical composition and physical status of
the lipid environment where they are embedded. The
decrease in membrane phospholipids due to an
increase in phospholipase A2 and C and increased
lipid peroxidation could be the reason for the
decreased enzyme activities [53]. The observed
decrease in SDH after CCl4 intoxication was in paral-
lel with the finding of Rusu et al. [54]. This decrease
in enzyme activity was attributed to the increase in
free radicals that affected the inner mitochondrial
membrane and intracellular calcium stores led to
structural and functional disorganization, over all loss
in energy production, irreversible damage, and loss of
enzymatic activity [55,56]. Rusu et al. [54] and De-
Andrade Belo et al. [57] confirmed the decrease in
hepatic LDH after CCl4 intoxication. Enzyme inhibi-
tion was mainly due to increase membrane fluidity as
a result of ROS involvement, leads to enzyme leakage
into circulation [50]. The decrease in acid phosphatase
enzyme activity was in agreement with Kataria and
Singh [58] who observed the same alteration in AP
after CCl4 induction. Achliya et al. [59] mentioned
that the high level of serum AP indicated its
Figure 4 Photomicrograph of H&E and Masson’s trichrom liver
sections (100×) of CCl4 intoxicated rats (a,b,c), CCl4 treated
with ethanol extract (d,e) and CCl4 treated with chloroform
extract (f,g), CCl4 treated with petroleum ether extract (h,i),
CCl4 treated silymarin drug (j,k). Arrows indicate collagen
deposition and lymphocytes infiltrations. Small arrows indicate fat
vacuoles deposition and hepatocytes foamy appearance.
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the repair mechanisms after treatment to the rise of
phospholipids that coupled with thymidylate synthe-
tase and thymidine kinase which confirmed liver
regeneration.
Regulatory effect of ginger extracts and silymarin on
hepatic marker enzymes was documented in our study
as free radicals scavengers [60] that could in turn nor-
malize microsomes, lysosomes, mitochondria and
plasma membranes permeability and integrity which
lead to restore the hepatic enzymes to its normal
levels.
The most commonly associated characteristic of liver
fibrosis is the increased deposition of collagens. During
liver fibrosis, altered collagen synthesis at both mRNA
and protein levels is observed, with a dramatic increase
in type I collagen along with smaller, but significant,
increases in type III collagen. This increase in collagen
deposition gave an additional support of the observed
increase in liver weight and its ratio over body weight.
The excess deposition of extracellular matrix proteins
disrupts the normal architecture of the liver, alters its
normal function and ultimately leading to pathophysio-
logical damage [61]. The most remarkable pathological
characteristics of CCl4 -induced hepatotoxicity are
massive centrilobular necrosis, ballooning degenera-
tion, cellular infiltration and steatosis [42]. This was in
accordance with the present finding of massive defor-
mation of hepatic cells architecture. In ginger and sily-
marin treated groups, hepatocyte degeneration,
necrosis and infiltration of inflammatory cells were all
apparently ameliorated. Collagen deposition was mark-
edly reduced. Minimal deposition of fat vacuoles was
apparently observed. Silymarin has anti-fibrotic and
anti inflammatory effects, inhibit activation of hepatic
stellate cells through the expression of transforming
growth factor-beta1 and stabilization of mast cells [62].
We compare the anti-fibrogenic effects of silymarin
with extracts and the results exhibited that ethanol
extract had higher potency in inhibiting collagen
deposition and fibrosis severity.
Conclusions
Ginger has the ability to down regulate free radicals ele-
vation, improve liver and cholestatic biomarkers, amelio-
rate hepatic marker enzymes, reduce collagen
deposition, fibrosis severity and normalize the hepatic
cells architecture. Ginger ethanolic extract recorded the
most potent effect in improving the selected parameters.
The hepatoprotective effect of Z. officinale demonstrated
in this study may explore its nutraceutical role in
human diet. Therefore, further studies are need for its
clinical application.
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